C-terminally truncated interferon
View Patent ↗The invention described herein provides a C-terminally truncated interferon having a deletion of 7, 8, or 9 amino acids and having enhanced biological activity, and the polynucleotides encoding such an interferon. Also provided are methods for producing and using such truncated interferon. In some embodiments, the truncated interferon is produced in a plant.
1. An artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced anti-proliferative activity as compared to full length interferon, wherein said C-terminally truncated interferon consists of amino acids 1-156 of SEQ ID NO:2.
2. The artificial polynucleotide of claim 1 further comprising a nucleotide sequence that encodes the amino acid sequence of an extensin signal peptide.
3. The artificial polynucleotide of claim 1 , wherein said polynucleotide comprises a fragment of SEQ ID NO: 1 consisting of nucleotides 1-468.
4. A host plant cell comprising an expression vector wherein said vector comprises an artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced anti-proliferative activity as compared to full length interferon, wherein said C-terminally truncated interferon consists of amino acids 1-156 of SEQ ID NO:2.
5. A process for producing a polypeptide comprising a C-terminally truncated interferon having enhanced anti-proliferative activity as compared to full length interferon; said process comprising transforming a plant with an expression vector wherein said vector comprises an artificial polynucleotide encoding a polypeptide comprising said C-terminally truncated interferon, wherein said C-terminally truncated interferon consists of amino acids 1-156 of SEQ ID NO:2.
6. The process of claim 5 comprising infecting the plant with a viral vector comprising the expression vector.
7. The process of claim 5 wherein the expression vector further comprises a nucleotide sequence that encodes the amino acid sequence of an extensin signal peptide.
8. The process of claim 5 comprising stably incorporating the expression vector into the genome of the plant.
9. A plant comprising an expression vector wherein said vector comprises an artificial polynucleotide encoding a polypeptide comprising a C-terminally truncated interferon having enhanced anti-proliferative activity as compared to full-length interferon, wherein said C-terminally truncated interferon consists of amino acids 1-156 of SEQ ID NO:2.
10. The plant of claim 9 wherein the expression vector is a viral vector.
11. The plant of claim 9 wherein the expression vector is stably incorporated into the plant genome.